Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11524 posts found.

sanofi_hq_reception_close

EMA’s CHMP recommends Sanofi’s Humalog biosimilar

May 22, 2017 Manufacturing and Production, Sales and Marketing Eli Lilly, Humalog, Sanofi

Sanofi has received a positive recommendation by the CHMP for its biosimilar to Eli Lilly’s Humalog. The recommendation for approval …
News
janeg

J&J lines up its Global Head for Actelion

May 22, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Actelion, Janssen, Johnson & Johnson

The deal is not yet complete but the last steps are assumed to be a formality – at least Johnson …
Appointment

Behind the NHS recruitment crisis

May 22, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NHS, NHS Providers

NHS Providers, the membership organisation and trade association for the NHS, laid a stark warning at the door of the …
Feature
sanofi_new_paris_hq

Sanofi Zika vaccine deal causes controversy

May 22, 2017 Sales and Marketing Sanofi, US army, Zika

In a further twist to Sanofi’s deal with the US Army to develop a vaccine for the Zika virus, the …
News

Novartis cuts 500 traditional roles for 350 ‘high-tech’ ones

May 22, 2017 Manufacturing and Production, Research and Development, Sales and Marketing Novartis

Novartis has announced a restructure within the company which will lead to the transfer or loss of 500 traditional production …
News
amgen_hq

Amgen hit by major safety blow on osteoporosis drug

May 22, 2017 Research and Development, Sales and Marketing Amgen, Romosozumab, UCB SA

Amgen and UCB SA have been delivered a crushing blow in its attempt to have a drug for osteoporosis approved …
News

70 patients sue Pfizer over arthritis drug risks

May 22, 2017 Sales and Marketing Pfizer, celebrex

Pfizer has been hit with a £3.5 million lawsuit by 70 Scottish patients who claim that the use of its …
News
astrazeneca_logo_building

AstraZeneca sells off rights to beta-blocker for $300 million

May 22, 2017 Sales and Marketing AstraZeneca, Recordati, Seloken

AstraZeneca announced that it had sold the European rights to its drug, Seloken (metoprolol), to Italian pharmaceutical company Recordati. The …
News
abbviehqe_011_low

AbbVie suffers knock to Humira patent

May 19, 2017 Medical Communications, Sales and Marketing AbbVie, Humira, patents

Humira is the largest selling pharmaceutical drug in the world. The treatment for rheumatoid arthritis brought in over $16 billion …
News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

May 19, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing top ten

With every week we draw closer to the event everyone in the UK is talking about – the general election. …
News
gavel

J&J launches lawsuit to block release of Remicade biosimilar

May 19, 2017 Medical Communications, Sales and Marketing J&J, JJ, Remicade, Samsung Bioepis

Samsung Bioepis gained approval to launch its biosimilar to Johnson & Johnson’s Remicade just last month, on 21 April, but …
News
facilities_lg06

Dr Reddy’s gets greenlight to market Doxil generic

May 18, 2017 Sales and Marketing Dr Reddy's, FDA

Dr Reddy’s Laboratories, one of India’s largest pharmaceutical firms, has revealed that the FDA has given the go-ahead to market …
News

FDA approves first ALS/Lou Gehrig’s disease therapy in 22 years

May 18, 2017 Research and Development, Sales and Marketing Mitsubishi Tanabe Pharma, als

The FDA has announced that it has approved Mitsubishi Tanabe Pharma’s Radicava (edaravone) for the treatment of amyotrophic lateral sclerosis(ALS), …
News

Bayer celebrates FDA priority review for investigational blood cancer drug

May 17, 2017 Research and Development, Sales and Marketing Bayer, FDA, blood cancer

Bayer has announced that its investigational blood cancer treatment copanlisib has been awarded priority review designation from the FDA, meaning …
News

FDA demands new warnings for J&J diabetes drug over amputation risk

May 17, 2017 Manufacturing and Production, Research and Development, Sales and Marketing J&J, JJ, Johnson & Johnson, diabetes

Johnson & Johnson has found itself in deep water again over the potentially harmful effects of its products. This time …
News
The Gateway to Local Adoption Series

Latest content

Thermo Fisher opens new distribution centre in Ireland

March 12, 2026

Altimetrik appoints Dhirendra Nath as Chief Human Resources Officer

March 12, 2026

Kindeva appoints Mike Cowhig as Chief Legal Officer

March 11, 2026

DiaMedica gets regulatory clearance from Health Canada for phase 2 preeclampsia study

March 11, 2026

Abselion establishes a US subsidiary in Massachusetts 

March 10, 2026